Next-generation ovarian cancer solution: innovative biomarker technology enabling early detection, precise diagnosis, and personalised treatment plan development for improved outcomes in high-grade serous ovarian carcinoma (HGSOC)
Improved methods of manufacturing and purification processes for adenoviral vectored vaccines, oncolytic viruses and gene therapies to high Titre, with low cost of goods.
A method for generating ex vivo models of the bone and bone marrow, which involves the use of a fragmented gel as a 3D scaffold to drive vascularisation and differentiation.